Transactivation_NN
by_IN
CIITA_NN
,_,
the_DT
type_NN
II_CD
bare_JJ
lymphocyte_NN
syndrome-associated_JJ
factor_NN
,_,
requires_VBZ
participation_NN
of_IN
multiple_JJ
regions_NNS
of_IN
the_DT
TATA_NN
box_NN
binding_NN
protein_NN
._.

CIITA_NN
is_VBZ
a_DT
positive_JJ
regulator_NN
of_IN
class_NN
II_CD
major_JJ
histocompatibility_NN
complex_NN
gene_NN
transcription_NN
that_WDT
has_VBZ
been_VBN
found_VBN
to_TO
be_VB
defective_JJ
in_IN
one_CD
of_IN
the_DT
five_CD
complementation_NN
groups_NNS
of_IN
class_NN
II_CD
major_JJ
histocompatibility_NN
complex-negative_JJ
cell_NN
lines_NNS
._.

Its_PRP$
N-terminal_JJ
region_NN
is_VBZ
capable_JJ
of_IN
activating_VBG
transcription_NN
from_IN
a_DT
reporter_NN
gene_NN
when_WRB
fused_VBN
to_TO
a_DT
DNA_NN
binding_NN
domain_NN
._.

We_PRP
have_VBP
investigated_VBN
the_DT
mechanism_NN
of_IN
transactivation_NN
mediated_VBN
by_IN
the_DT
CIITA_NN
activation_NN
domain_NN
by_IN
studying_VBG
its_PRP$
role_NN
in_IN
the_DT
process_NN
of_IN
transcription_NN
initiation_NN
and_CC
elongation_NN
._.

Specifically_RB
the_DT
altered_JJ
specificity_NN
TBP_NN
-LRB-_-LRB-
TATA_NN
box_NN
binding_NN
protein_NN
-RRB-_-RRB-
assay_NN
has_VBZ
been_VBN
used_VBN
to_TO
analyze_VB
the_DT
response_NN
of_IN
the_DT
CIITA_NN
activation_NN
domain_NN
to_TO
mutations_NNS
in_IN
TBP_NN
known_VBN
to_TO
disrupt_VB
its_PRP$
interaction_NN
with_IN
its_PRP$
associated_JJ
general_JJ
factors_NNS
._.

Transactivation_NN
by_IN
CIITA_NN
was_VBD
extremely_RB
sensitive_JJ
to_TO
a_DT
mutation_NN
in_IN
TBP_NN
that_WDT
in_IN
yeast_NN
is_VBZ
known_VBN
to_TO
abolish_VB
VP16-mediated_JJ
transcription_NN
but_CC
leaves_VBZ
basal_JJ
transcription_NN
unaffected_JJ
._.

A_DT
TBP_NN
mutant_NN
defective_JJ
in_IN
interaction_NN
with_IN
TBP-associated_JJ
factor_NN
TAFII250_NN
also_RB
failed_VBD
to_TO
mediate_VB
transactivation_NN
through_IN
the_DT
CIITA_NN
activation_NN
domain_NN
._.

Certain_JJ
interactions_NNS
between_IN
TBP_NN
and_CC
general_JJ
factors_NNS
that_WDT
are_VBP
specifically_RB
required_VBN
for_IN
acidic_JJ
activation_NN
domains_NNS
were_VBD
also_RB
required_VBN
for_IN
CIITA-mediated_JJ
transactivation_NN
to_TO
reach_VB
its_PRP$
full_JJ
potential_NN
._.

Finally_RB
,_,
like_IN
VP16_NN
,_,
CIITA_NN
was_VBD
able_JJ
to_TO
stimulate_VB
elongation_NN
of_IN
transcription_NN
._.

Overall_RB
the_DT
mechanism_NN
of_IN
transactivation_NN
by_IN
the_DT
human_JJ
B-cell-specific_JJ
CIITA_NN
is_VBZ
very_RB
similar_JJ
to_TO
that_DT
mediated_VBN
by_IN
the_DT
herpes_NN
virus_NN
transactivator_NN
VP16_NN
in_IN
the_DT
ways_NNS
that_WDT
have_VBP
been_VBN
tested_VBN
._.

